Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net (loss)	$ (3,454,231)	$ (708,055)
Adjustments to reconcile net (loss) to net cash (used in) operating activities
Common stock issued for services rendered	2,955,915	299,333
Amortization of discount to note payable	259,178
Derivative expense	586,195
Changes in fair value of derivative liabilities	(969,566)
Accounts payable and accrued expenses	(4,283)	33,571
Due from related party	(131,542)	(21,970)
Net cash (used in) operating activities:	(758,334)	(397,121)
Patent		(7,000)
Net cash (used in) investing activities:		(7,000)
Proceeds from issuance of common stock	97,500	250,000
Proceeds from exercise of options		7,500
Proceeds from exercise of warrants	131,000
Proceeds from promissory note	50,000
Proceeds from issuance of note payable	2,400,000
Redemption of note payable	(1,951,400)
Net cash provided by financing activities	727,100	257,500
Net increase/(decrease) in cash and cash equivalents	(31,234)	(146,621)
Cash and cash equivalents, beginning of year	95,069	152,526
Cash and cash equivalents, end of year	63,836	5,905
Interest
Income taxes